Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors

Laboratory Investigation

Volumn 79, Issue 2, 1999, Pages 213-223

  Papapetropoulos, Andreas ^a,c   García Cardeña, Guillermo ^a   Dengler, Thomas J ^a   Maisonpierre, Peter C ^b   Yancopoulos, George D ^b   Sessa, William C ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

ANGIOPOIETIN-1; CELL MOVEMENT; CELL SURVIVAL; COLLAGEN; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; GELS; GROWTH SUBSTANCES; HUMANS; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE;

EID: 0344450778     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Adams JM and Cory S (1991). Transgenic models of tumor development. Science 254:1161-1167.
2. Alexander CM, Howard EW, Bissell MJ, and Werb Z (1996). Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol 135:1669-1677.
3. Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B, and Apte SS (1996). A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumour growth. Biochem Cell Biol 74:853-862.
4. Bissell MJ and Hall HG (1987). Form and function in the mammary gland. The role of extracellular matrix. In: Neville MC, Daniel CW, editors. The mammary gland: development, regulation and function. NY: Plenum Press, 97-146.
5. Bancroft JD and Stevens A (1982). Theory and practice of histological techniques, 2nd ed. London: Churchill Livingston, 142-143.
6. Bravo R and MacDonald-Bravo H (1987). Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 105:1549-1554.
7. Chambers AF and Matrisian LM (1997). Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260-1270.
8. Christofori G, Naik P, Hanahan D (1994). A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414-417.
9. Corcoran ML and Stetler-Stevenson WG (1995). Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J Biol Chem 270: 13453-13459.
10. D'Armiento J, DiColandrea T, Dalal SS, Okada Y, Huang MT, Conney AH, et al (1995). Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol 15: 5732-5739.
11. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, and Livingston DM (1988). SV40 large tumour antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275-283.
12. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, and Taylor SM (1992). Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701-708.
13. Garcia RL, Coltrera MD, and Gown AM (1989). Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 26:733-739.
14. Gomez DE, Alonso DF, Yoshiji H, and Thorgeirsson UP (1997). Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74:111-122.
15. Hanahan D and Folkman J (1996). Patterns of emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
16. Hay ED (1993). Extracellular matrix epithelial differentiation. Curr Opinion Cell Biol. 5:1029-1035.
17. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, and Iwata K (1992). Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298:29-32.
18. Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N, and Polverini PJ (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160:194-202.
19. Inderdeo DS, Edwards DR, Han VKM, and Khokha R (1996). Temporal and spatial expression of tissue inhibitors of metalloproteinases during the natural ovulatory cycle of the mouse. Biol Reprod 55:498-508.
20. Khokha R (1994). Suppression of the tumourigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of metalloproteinases-1. J Natl Cancer Inst 86:299-304.
21. Khokha R, Zimmer MJ, Graham CH, Lala PK, and Waterhouse P (1992). Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 84:1017-1022.
22. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, and Groom A (1994). Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 54: 4791-4797.
23. Kossakowska AE, Urbanski SJ, and Edwards DR (1991). Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood 77:2475-2481.
24. Krüger A, Fata JE, and Khokha R (1997). Altered tumor growth and metastasis of a T-cell lymphoma in TIMP-1 transgenic mice. Blood 90:1993-2000.
25. Krüger A, Sanchez-Sweatman OH, Martin DC, Orr FW, Rüther U, and Khokha R (1998). Host TIMP-1 overexpression confers resistance to experimental brain metastasis. Oncogene 16:2319-2423.
26. Lardelli P, Perentes E, Meier G, Navarro N, and Ettlin RA (1994). Quantification of hepatocytic proliferation in the laboratory mouse. Exp Toxic Pathol 46:95-100.
27. Lenzi R, Alpini G, Liu MH, Rand JH, and Tavoloni N (1990). Von Willebrand factor antigen is not an accurate marker of rat and guinea pig liver endothelial cells. Liver 10:372-379.
28. Liotta LA, Steeg PS, and Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-336.
29. Martin DC, Rüther U, Sanchez-Sweatman OH, Orr FW, and Khokha R (1996). Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogene 13:569-576.
30. Martinez-Hernandez A and Amenta PS (1989). The extracellular matrix in hepatic regeneration. FASEB J 9:1401-1410.
31. Matrisian LM (1992). The matrix-degrading metalloproteinases. Bioessays 14:455-463.
32. Murphy AN, Unsworth EJ, and Stetler-Stevenson WG (1993). Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 157:351-358.
33. Ruck P, Xiao J-C, and Kaiserling E (1995a). Immunoreactivity of sinusoids in hepatocellular carcinoma. Arch Pathol Lab Med 119:173-178.
34. Ruck P, Xiao J-C, and Kaiserling E (1995b). Immunoreactivity of sinusoids in hepatoblastoma: an immunohistochemical study using lectin UEA-1 and antibodies against endothelium-associated antigens, including CD34. Histopathology 26:451-455.
35. Rüther U, Woodroofe C, Fattori E, and Ciliberto, G (1993). Inducible formation of liver tumours in transgenic mice. Oncogene 8:87-93.
36. Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, and Gabbert HE (1996). Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res 16:2117-2121.
37. Sato K, Yoo YC, Mochizuki M, Saiki I, Takahashi TA, and Azuma I (1995). Inhibition of tumor-induced angiogenesis by a synthetic lipid A analogue with low endotoxicity. Jpn J Cancer Res 86:374-382.
38. Stewart N and Bacchetti S (1991). Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology 180:49-57.
39. Sympson CJ, Bissell MJ, and Werb Z (1995). Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Cancer Biol 6:159-163.
40. Takigawa M, Nishida Y, Suzuki F, Kishi J, Yamashita K, and Hayakawa T (1990). Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun 171:1264-1271.
41. Talhouk RS, Bissell MJ, and Werb Z (1992). Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118:1271-1282.
42. Tan TH, Wallis J, and Levine AJ (1986). Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex. J Virol 59:574-583.
43. Thrailkill KM, Quarles LD, Nagase H, Suzuki K, Serra DM, and Fowlkes JL (1995). Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136:3527-3533.
44. Visscher DW, Hoyhtya M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD, and Fridman R (1994). Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumour recurrence. Int J Cancer 59:339-344.
45. Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, and Shi YE (1997). Inhibition of tumour growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 14:2767-2774.
46. Werb Z (1997). ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91:439-442.
47. Wilson CL, Heppner GH, Labosky PA, Hogan BL, and Matrisian LM (1997). Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci. USA 94:1402-1407.
48. Witty JP, Lempka T, Coffey RJ Jr, and Matrisian LM (1995). Decreased tumour formation in 7:12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res 55:1401-1406.
49. Yoshiji H, Gomez DE, and Thorgeirsson UP (1996). Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer. Int J Cancer 69:131-134.